Cite
MLA Citation
S. Stacchiotti et al.. “Patient-derived solitary fibrous tumour xenografts predict high sensitivity to doxorubicin/dacarbazine combination confirmed in the clinic and highlight the potential effectiveness of trabectedin or eribulin against this tumour.” European journal of cancer, vol. 76, 2017, pp. 84–92. http://access.bl.uk/ark:/81055/vdc_100045252645.0x000063